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Abstract
Nemaline myopathy (NM) is a skeletal muscle disorder caused by mutations in genes that are generally involved in muscle 
contraction, in particular those related to the structure and/or regulation of the thin filament. Many pathogenic aspects of 
this disease remain largely unclear. Here, we report novel pathological defects in skeletal muscle fibres of mouse models 
and patients with NM: irregular spacing and morphology of nuclei; disrupted nuclear envelope; altered chromatin arrange-
ment; and disorganisation of the cortical cytoskeleton. Impairments in contractility are the primary cause of these nuclear 
defects. We also establish the role of microtubule organisation in determining nuclear morphology, a phenomenon which 
is likely to contribute to nuclear alterations in this disease. Our results overlap with findings in diseases caused directly by 
mutations in nuclear envelope or cytoskeletal proteins. Given the important role of nuclear shape and envelope in regulating 
gene expression, and the cytoskeleton in maintaining muscle fibre integrity, our findings are likely to explain some of the 
hallmarks of NM, including contractile filament disarray, altered mechanical properties and broad transcriptional alterations.
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Introduction
Nemaline myopathy (NM) is a genetically heterogeneous 
disease of skeletal muscle caused by mutations in genes that 
are generally involved in muscle contraction, in particular 
those related to the structure and/or regulation of the thin fil-
ament. Mutations in ACTA1 (skeletal muscle actin) or NEB 
(nebulin) together make up the majority of cases, whilst 
other causative genes (to date, TPM3, TPM2, TNNT1, CFL2, 
KBTBD13, KLHL40, KLHL41, LMOD3, MYPN, RYR3 or 
MYO18B) together with unidentified genes, are implicated 
in the remainder [20, 38]. These mutations result in weak-
ness at the contractile level, while other cellular pathological 
hallmarks include dense accumulations of proteins known as 
nemaline rods, arrested muscle fibre growth, impaired fibre 
type differentiation, and disarray of contractile filaments 
[20]. However, the underlying mechanisms behind many of 
these features remain uncertain, even though the mutations 
affecting thin filament structure and function are likely to be 
involved [7, 17, 28, 29, 40, 42, 60, 63]. In the present study, 
we aimed to acquire a clearer understanding of muscle fibre 
dysfunction in NM by specifically studying nuclei and the 
related cortical cytoskeleton.
Skeletal muscle fibres are large syncytial cells containing 
many, often hundreds, of nuclei (termed myonuclei). Suffi-
cient numbers and regular spacing of myonuclei throughout 
the muscle fibre are a prerequisite for its function, allowing 
the efficient delivery of gene products to all parts of the cell, 
with minimal transport distances. Therefore it is thought 
that each nucleus is responsible for maintaining a certain 
volume of the muscle fibre, termed the myonuclear domain 
[5, 32]. The nuclei of skeletal muscle fibres are linked with 
various cytoskeletal components including non-sarcomeric/
cytoplasmic actins, microtubules and intermediate filaments 
such as desmin. All three of these cytoskeletal networks have 
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s0040 1-019-02034 -8) contains 
supplementary material, which is available to authorized users.
 * Jacob A. Ross 
 jacob.ross@kcl.ac.uk
Extended author information available on the last page of the article
478 Acta Neuropathologica (2019) 138:477–495
1 3
been implicated in the spacing and positioning of nuclei in 
models of skeletal muscle development: microtubules in the 
initial translocation/spacing of nuclei along the fibre [12, 14, 
15, 35], and actin and desmin in their movement to the fibre 
periphery [45].
At the organelle level, nuclear function and transcription 
are regulated by a host of external factors; the nuclear enve-
lope acts as a signalling hub that is capable of transducing a 
range of chemical and mechanical signals to regulate gene 
expression [18, 34, 58]. The cytoskeleton is known to regu-
late nuclear shape and morphology via interactions with the 
nuclear envelope [10, 23], a process which can itself impact 
on gene transcription, with different morphologies being 
linked to cell type, function, differentiation, and disease 
states [10, 23, 62]. Given that the force-generating properties 
of NM muscle fibres are severely limited, we hypothesised 
that cytoskeletal components as well as nuclear function, 
positioning and integrity might be affected in this disease, 
and possibly contribute to pathology.
Using single muscle fibres from mouse models and NM 
patients with mutations in ACTA1 or NEB, we found that 
myonuclei display a range of defects, including irregular 
spacing and morphology, abnormal nuclear envelope and 
altered chromatin distribution. We also observed severe 
disruption within the microtubule, desmin and cytoplasmic 
(β- and γ-) actin networks, as well as alterations in their 
anchorage at the nuclear surface. We next sought to inves-
tigate the underlying pathological mechanisms, and found 
that impaired contractile force production is responsible for 
the nuclear spacing and morphological defects. We further 
demonstrated the role of a properly organised microtubule 
network in regulating nuclear shape. Our findings suggest 
that these alterations are likely to contribute to some of the 
features observed in NM, which include: broad transcrip-
tional alterations and hindered muscle fibre growth [30, 
32] (perhaps due to the nuclear disruption which is likely 
to affect gene expression programmes); myofibril disarray 
(since desmin and the nuclear envelope are known to con-
tribute to their organisation [1, 6]); and altered mechanical 
properties of muscle fibres (known to be related in part to the 
cortical cytoskeleton) [21]. In addition, our results suggest 
that nuclear and cytoskeletal defects might be a secondary 
feature and/or source of pathology in other (muscle) dis-
eases, even in those where these structures are not primarily 
affected.
Materials and methods
Human subjects
All tissue was consented, stored, and used in accordance 
with the Human Tissue Act, UK, under local ethical approval 
(REC 13/NE/0373). Details of patients providing samples 
for light microscopy are given in Table 1, and of patients 
for electron microscopy in Tables 2 and 3. No electron 
Table 1  Nemaline myopathy patient muscle biopsy samples used for light microscopy
Age at biopsy is given (years)
Gene Age M/F Mutation (DNA) Mutation (protein) Source
ACTA1 20 M c.16G>A E6K Copenhagen, Denmark
ACTA1 30 F c.841T>C Y281H Genoa, Italy
NEB 36 F c.2836-2A>G and c.5763+5G>A Mutation in splice site Copenhagen, Denmark
NEB 56 M c.17234C>T and c.2271_22713del R5745X and K7571del Copenhagen, Denmark
NEB 71 F c.508-7T>A and c.19097G>T Mutation in splice site; and S6366I Helsinki, Finland
Table 2  Nemaline myopathy patient muscle biopsy samples used for electron microscopy
Age at biopsy is given (years, unless otherwise specified)
Gene Age M/F Mutation (DNA) Mutation (protein) Source
NEB 2 (a) M c.17737-2A>T and c.21315delA Mutation in splice site and R7105 frameshift Milan, Italy
NEB 2 (b) M c.4082+5G>T (splice site) and g.112388C>T Mutation in splice site and Q>X Milan, Italy
NEB 17 M c.22249A>C and c.8392-8395 duplication T7417P and R2799L frameshift Helsinki, Finland
NEB 23 M c.11164C>T and c.19097G>T R3722* (nonsense) and S6366I Helsinki, Finland
NEB 30 F c.508-7T>A and c.19097G>T Mutation in splice site and S6366I Helsinki, Finland
ACTA1 11 weeks F c.796T>C F226L London, UK
ACTA1 3 M c.235A>G T79A Milan, Italy
ACTA1 10 M c.841T>C Y281H Milan, Italy
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microscopy samples were available from the patients used 
for light microscopy studies, hence, the different cohorts of 
patients for the two techniques.
Mouse models
Acta1H40Y mouse tibialis anterior muscle samples, with and 
without transfer of the Myl4 gene remained frozen from a 
previous study [30]. To summarise, data were collected from 
four wild type and four mutant male mice. At 4 weeks of 
age, the compartment containing the tibialis anterior mus-
cle was injected with rAAV6 virus containing the Myl4 
transgene, and contralateral legs served as controls, being 
injected with virus lacking the functional gene. Mice were 
sacrificed 4 weeks later at 8 weeks of age. Colony mainte-
nance and experiments were approved by the Uppsala Local 
Ethical Committee on Animal Research.
Neb cKO mice [28] were maintained at the University of 
Arizona in accordance with the US National Institutes of 
Health guidelines “Using Animals in Intramural Research”. 
Mutants and WT/heterozygous littermates were sacrificed at 
3 months of age by cardiac perfusion with 4% paraformal-
dehyde (PFA)/PBS, to properly preserve microtubule struc-
ture. Extensor digitorum longus muscles were dissected for 
whole-mount immunolabelling of cytoplasmic (β- and γ-) 
actins, desmin or microtubules (see below).
Antibodies
Primary antibodies were as follows (species, isotype, manu-
facturer, catalogue number, and dilution are given): lamin 
A (mouse monoclonal IgG3, Abcam, ab8980, 1:200); 
nesprin-1 (rabbit monoclonal IgG, Abcam, ab192234, 
1:400); pericentrin (rabbit polyclonal IgG, Abcam, ab4448, 
1:200); β-tubulin (clone TUB2.1, mouse monoclonal IgG1, 
Santa Cruz, sc-58886, 1:500); desmin (clone D33, mouse 
monoclonal IgG1, Dako, M076001-2, 1:400); β-actin (rab-
bit polyclonal IgG, Abcam, ab8227, 1:300); γ-actin (clone 
2A3, mouse monoclonal IgG2b, Bio-Rad, MCA5776GA, 
1:300); acetyl lys9/lys14 histone H3 (rabbit polyclonal IgG, 
cell signaling, #9677, 1:200).
Enzymatic isolation and culture of intact single 
muscle fibres
Intact single muscle fibres were prepared as described pre-
viously, using enzymatic dissociation with collagenase I 
(Sigma Aldrich) and gentle trituration (Sigma Aldrich) [47]. 
After isolation, fibres were plated into 6-well plates (~ 30 
fibres per well) in DMSO/high glucose/GlutaMAX supple-
ment/pyruvate (Thermo Fisher Scientific, Cat# 31966021), 
containing 10% horse serum and 1% penicillin/streptomy-
cin solution. Freshly isolated fibres were treated overnight 
with nocodazole (20 μM), taxol (10 μM) or epothilone D 
(10 μM). Final DMSO (vehicle) concentration was 0.5% in 
all cases. To assess myonuclear spacing, fibres were cultured 
for 72 h in the presence of the aforementioned drugs.
Immunohistochemistry (single muscle fibres)
Myofibres were fixed in 4% PFA/PBS for 15 min, and 
washed 3× in PBS. Fibres were permeabilised in 0.1% triton-
X/PBS for 10 min, washed 3× and blocked in 10% normal 
goat serum/PBS for 1 h. Fibres were then treated with pri-
mary antibodies in blocking solution overnight (β-tubulin) or 
for 3 h (lamin A, nesprin-1, pericentrin) at 4 °C. Fibres were 
washed 3× in PBS for a total of 30 min, and then treated 
with Alexa 594 or 488-conjugated secondary antibodies and 
DAPI (all at 1:1000 in PBS) for 3 h. Fibres were washed 3× 
in PBS for a total of 30 min and mounted in Fluoromount 
mounting medium (Southern Biotech) with coverslip (thick-
ness #1.5).
Immunohistochemistry (whole‑mount muscles)
Neb cKO mice and WT/heterozygous littermates (all female) 
were sacrificed at 3 months of age by cardiac perfusion with 
4% PFA/PBS, to properly preserve microtubule structure. 
Extensor digitorum longus muscles were dissected for 
whole-mount immunolabelling of cytoplasmic (β- and γ-) 
actins, desmin or microtubules. Muscles were then permea-
bilised in 0.5% triton-X/PBS (20 min) and 0.1% Triton-X/
PBS (20 min), with each solution being replaced at least 
once during the incubation. Samples were then blocked in 
mouse-on-mouse block/PBS for 3 h, and then blocked in 8% 
bovine serum albumin overnight. Primary antibodies (tubu-
lin, cytoplasmic actins) in blocking buffer were applied for 
5 h, followed by 2 h washing in 0.1% triton-X/PBS.
Table 3  Patients with sporadic late-onset nemaline myopathy 
(SLONM), used for electron microscopy
Ages at biopsy/examination and age of onset are shown in years. 
SLONM 1 and 2 correspond to patients 4 and 6 in Monforte et  al. 
[36]; SLONM 3, 4 and 5 correspond to patients 2, 5, and 6 in Schnit-
zler et al. [53]. All patients were HIV-negative
Patient Age Age of onset M/F Monoclonal 
gammopathy
Source
SLONM 1 65 64 M IgG lambda Rome, Italy
SLONM 2 69 68 F Not available Rome, Italy
SLONM 3 72 67 F No Leuven, 
Belgium
SLONM 4 79 54 F Not available Leuven, 
Belgium
SLONM 5 34 32 F No Leuven, 
Belgium
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Fluorescence imaging
Fibres were imaged on a Zeiss Axiovert 200 spinning disc 
confocal microscope equipped with BD CARV II and a 
motorised Z drive at 20× magnification (for imaging of 
nuclear morphology and nuclear envelope). For nuclear 
number and distribution, Z-stacks with 1 μm Z increments 
were taken through the entire depths of fibres, as described 
previously [48, 49]. For imaging of cytoskeleton and nuclear 
volume, a Nikon A1 laser scanning confocal microscope 
with a 100× oil immersion objective (1.4 NA) was used, 
with Z-stacks taken with 0.3 μm Z increments (Nikon Imag-
ing Centre, King’s College London).
Image analysis
Analysis of nuclear number and spacing: Coordinates of 
myonuclei were identified in 3D within Z-stacks of mus-
cle fibres. A custom-made Matlab programme was used to 
a measure fibre CSA, nuclear number, nearest neighbour 
distances and order score (‘g’) of nuclei within fibres, as 
described previously [4, 48].
Analysis of nuclear shape parameters: For 2- and 
3-dimensional measurements (area, aspect ratio, circularity, 
and volume), nuclei in the DAPI channel were thresholded 
by pixel intensity until fully highlighted. Inbuilt ImageJ 
functions were used to measure 2D parameters and Voxel 
Counter plugin for volume. For accurate shape analysis, 
nuclei positioned on the sides or the backs of fibres (relative 
to the microscope objective) were excluded, as were those 
in clusters where nuclei were touching.
Microtubule quantifications: density (% area) was calcu-
lated on binary converted images in ImageJ. Microtubule 
directionality was calculated using the TeDT tool [31].
Statistics
Graphs were prepared and analysed in Graphpad Prism. 
Linear regression lines and statistical comparisons were 
performed using inbuilt algorithms (ANCOVA test was 
used to compare elevations/intercepts and slopes of differ-
ent regression lines). For statistical comparisons of nuclear 
organisation and nuclear shape in human subjects (column 
graphs), control data points were pooled, since no significant 
age-related differences were observed amongst healthy con-
trol subjects. Owing to the different origins of disease (muta-
tion and gene affected), patient data points were not pooled. 
One-way ANOVA with Tukey post-correction was used to 
compare each patient against the pooled controls; in addi-
tion, a random effect algorithm was incorporated into the 
model, to account for any potential inter-individual differ-
ences that might exist amongst the control cohort. For stud-
ies with animals, no significant differences were observed 
between animals of the same genotype, and as such, individ-
ual data points for both control and mutant/treated animals 
were pooled. For column comparisons in the animal studies, 
a two-tailed t test was used to compare two groups, and a 
one-way ANOVA with Tukey post-correction was used to 
compare more than two groups. For drug treatments with 
nocodazole, taxol, and epothilone D in ex vivo culture exper-
iments, a cumulative probability test (Kolmogorov–Smirnov 
test) was used to compare groups against control/vehicle 
only. Asterisks denote the following statistical significance 
levels: *P < 0.05), **P < 0.01, ***P < 0.001.
Results
Muscle fibres from NM patients have misshapen 
and mispositioned nuclei with altered chromatin 
organisation
To assess myonuclear distribution in patients with NM, sin-
gle skeletal muscle fibres were teased from biopsy samples, 
mounted, and labelled with rhodamine-labelled phalloidin 
to visualise actin (thus marking the dimensions of the fibre) 
and DAPI to label nuclei, and imaged in 3D. Ages of con-
trols were as follows: 20, 25, 25, 30, 30, 44, and 62. Ages of 
ACTA1 patients were 20 and 30, and ages of NEB patients 
were 36, 56, and 71 (patient details in Table 1). Muscle 
fibres were generally smaller in cross-sectional area (CSA) 
in patients compared with age-matched control subjects, a 
common characteristic of NM (as well as some other muscle 
disorders), although some fibres in NEB patients (ages 56 
and 71) displayed large CSA values, indicating some extent 
of fibre size disproportion (Fig. 1a, b). In one ACTA1 patient 
(aged 20) and all three NEB patients, there was a higher 
abundance of myonuclei within muscle fibres compared 
to control subjects, as observed in nearest neighbour dis-
tances (Fig. 1c; lower values indicating more densely packed 
nuclei), and in numbers of nuclei per length of fibre (Fig. 1e, 
f; across a range of fibre sizes/CSAs; linear regression lines 
were similar for all control subjects as shown in Suppl Fig. 
S1a, b (online resource); hence for visual clarity, control 
data were pooled in these graphs).
Order score, a measure of the regularity of nuclear spac-
ing, was also calculated [4]. Mean order score was signifi-
cantly lower in all patients compared with control subjects, 
indicating that nuclei were more unevenly distributed than 
in controls (Fig. 1d). No correlation between fibre CSA and 
order score was noted in most controls and patients, indi-
cating that nuclear distribution was not noticeably affected 
by fibre size (Suppl Fig. S1c, d). Central nuclei are a hall-
mark of certain neuromuscular disorders including muscular 
dystrophies; however, this was rare in NM patient fibres, 
with the vast majority of nuclei being located at the fibre 
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periphery, as expected. Overall, these results suggest that 
myonuclear positioning is altered in NM patients, and that 
there is often a higher density of myonuclei within fibres.
Given that the distribution of nuclei was perturbed in 
NM patient muscle fibres, we next wanted to determine if 
there were any alterations within the nuclei themselves. 
In control subjects (aged 25 and 30), nuclei generally 
possessed an elliptical shape, and nuclear envelope pro-
teins nesprin-1 and lamin A localised in a regular rim 
around the nuclear edges, as expected (Fig. 2a, control 
Fig. 1  Myonuclei are more abundant and unevenly spaced in patients 
with nemaline myopathy. Healthy control subjects and patients are 
denoted with their mutation and age. a Representative single skel-
etal muscle fibres from a control subject and patients with ACTA1 
or NEB mutations, labelled for actin (rhodamine phalloidin; red) 
and nuclei (DAPI; blue). b Fibre cross-sectional area (CSA) for con-
trols and patients. c Nearest neighbour distance between myonuclei 
within fibres; a smaller distance indicates greater density of nuclei. 
d Order score (g), an algorithm to assess the regularity of nuclear 
spacing [4]; a lower score indicates more irregular spacing and 
more nuclear clustering. e Comparison between controls and ACTA1 
patients: relationship between number of nuclei per mm of fibre 
length, and their CSA. f As for e, but comparing controls and NEB 
patients (graphs e and f separated for visual clarity). For regression 
lines, data points from control subjects were pooled since there were 
no significant inter-individual variations (full data available in Fig. 
S1a, b). Individual data points represent an individual skeletal mus-
cle fibre, with mean ± SEM, or linear regression lines. For column 
graphs, significance was determined using one-way ANOVA com-
paring each patient with a group consisting of all control data points 
pooled together (since no significant inter-individual variation was 
found amongst controls). ANCOVA was used to compare elevations/
intercepts and slopes of regression lines. Scale bar: 50 μm. *P < 0.05, 
**P < 0.01, ***P < 0.001
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Fig. 2  Nuclear morphology and nuclear envelope are altered in 
skeletal muscle fibres of nemaline myopathy patients. Healthy con-
trol subjects and patients are denoted with their mutation and age. 
a–d Representative images of myonuclei from healthy controls and 
NM patients with ACTA1 or NEB mutations, immunolabelled for 
lamin A (left panels), nesprin-1 (middle panels) and merged with 
DAPI (Lamin A, green; nesprin-1, red; DAPI blue). Myonuclei dis-
playing a normal shape and nuclear envelope; b irregular shape; c 
faint immunolabelling for lamin A and nesprin-1; d banded pattern 
across surface. Graph showing proportions of each nuclear pheno-
type for patients and two controls (e). Graphs showing shape quan-
tifications for nuclei: area (f), aspect ratio (g) and circularity (h). A 
larger aspect ratio denotes a more elongated shape; a higher circular-
ity denotes a more circular shape. Graphs (f–h) show one data point 
per nucleus analysed, taken from > 10 muscle fibres per subject, with 
mean ± SEM. For graph (f), an F test for variance was used, to report 
differences in spread/variability of each patient versus controls; for 
graphs g, h, one-way ANOVA was used to report differences in mean 
between each patient and a group consisting of both control subjects 
pooled together. Note differences in overall data distribution as well 
as mean values. Scale bar: 10  μm. NS not significant *P < 0.05), 
**P < 0.01), ***P < 0.001
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subject). However, in the two ACTA1 patients (ages 20 
and 30) and two NEB patients (ages 36 and 56) studied, 
> 50% of the myonuclei were altered in each case, dis-
playing various features including shape irregularities 
(Fig. 2b), faint immunolabelling of nuclear envelope pro-
teins (Fig. 2c), and a banded appearance across the nuclear 
surface (Fig. 2d). Varying proportions of these features 
were observed in the four patients analysed (Fig.  2e). 
Nuclear shape/elongation was further analysed using 
area (in the 2D X–Y plane), aspect ratio and circularity 
measures (Fig. 2f–h). Although the nuclear area was on 
average similar in controls and patients, the variability 
was significantly greater in patients (Fig. 2f). Nuclei in 
ACTA1 patients shifted towards a more elongated shape 
(larger aspect ratio, lower circularity), and nuclei in NEB 
patients towards a more circular shape (lower aspect ratio, 
higher circularity; Fig. 2g, h). Similar nuclear defects are 
observed in laminopathies, which are primary genetic 
disorders of the nuclear envelope, and include muscular 
dystrophies and multisystem disorders caused by muta-
tions in lamin A/C, nesprins and other genes [19]. Our 
results indicate that severe defects in nuclear envelope and 
morphology can also occur in diseases caused by muscle 
contractile dysfunction.
Next, ultrastructural imaging was carried out, revealing 
nuclear morphological and envelope defects in more detail 
(Fig. 3; see Table 2 for patient details). In NM patients, a 
proportion of myonuclei resembled those seen in healthy 
muscle tissue, being of normal shape, having a regular dis-
tribution of heterochromatin largely at the nuclear periphery, 
and with a nuclear envelope consisting of a continuous dou-
ble membrane (Fig. 3a, a′). However, various defects were 
also noted: clusters of nuclei (Fig. 3b); low chromatin den-
sity (i.e., high levels of euchromatin; Fig. 3c); high chroma-
tin density (i.e., high levels of heterochromatin; Fig. 3d, e, g, 
h); discontinuities in the nuclear envelope (arrows, Fig. 3d); 
invaginations (marked ‘inv’, Fig. 3e); regions of separation 
between inner and outer nuclear membranes (marked ‘sep’, 
Fig. 3e–h). Interestingly, in the latter cases, chromatin was 
never observed to fill the open regions, again suggesting that 
the abnormality was the result of separations between the 
two membranes, rather than breakage or disruption of both. 
Table 4 gives a semi-quantitative analysis of the patients 
studied, listing the various abnormal features and the rela-
tive frequency of occurrence. Fluorescence microscopy of 
acetylhistone H3 (Lys9/Lys14), a well-characterised marker 
of transcriptionally active regions of DNA [16, 24, 44], pro-
vided further evidence of chromatin redistribution within 
nuclei of patients relative to control subjects (Fig. 3i–k; 
image quantifications in Suppl Fig. S2, online resource). 
These results demonstrate alterations in the nuclear envelope 
and in chromatin organisation, which would be expected to 
affect nuclear function and transcriptional regulation.
Reduced cellular force production is responsible 
for myonuclear alterations in NM
To investigate potential mechanisms behind aberrant nuclear 
spacing and morphology in NM, we employed a severe 
model of the disease, the Acta1H40Y mouse [29, 37, 59]. In a 
recently published study, a gene therapy approach was used 
to enhance myosin force output, via the delivery of a myosin 
light chain isoform (MyL4) that is normally only expressed 
in developing skeletal muscles (schematic, Fig. 4a). This 
resulted in a partial rescue of the Acta1H40Y phenotype, 
including an improvement in muscle force production and 
an increase in muscle fibre size [30]. Thus, we aimed to 
determine whether an increase in force output could also 
rescue the nuclear defects observed in NM. Like patients 
with ACTA1 or NEB mutations, skeletal muscle fibres of 
Acta1H40Y mice showed an irregular distribution of myonu-
clei (Fig. 4b), which was quantifiable using the order score 
parameter (Fig. 4c). However, delivery of the Myl4 transgene 
resulted in the full restoration of nuclear spacing defects to 
wild-type levels (Fig. 4c). In addition, nuclear shape altera-
tions, including increased area and aspect ratio and reduced 
circularity (Fig. 4d–f), were also restored to wild-type values 
in muscles of Acta1H40Y mice treated with the transgene. 
These results suggest that in NM, force impairment results 
in nuclear spacing and morphological alterations, and that 
enhancing force production restores these parameters.
To gain further insight into whether force impairments 
affect nuclear structure in human subjects, we studied elec-
tron microscopy images of five patients with sporadic late-
onset nemaline myopathy (SLONM). This disease contrasts 
with typical NM cases, since it is an acquired condition that 
occurs in the absence of mutations in known disease-related 
genes. However, like NM of known genetic origin, on the 
histopathological level this disease presents with nemaline 
rods, sarcomeric disarray, and crucially, reduced capacity of 
muscle to generate force. Patient details are given Table 3, 
and were published in two recent studies [36, 53] (ages: 34, 
65, 69, 72, 79). A number of nuclear defects were observed 
in all five patients, and recapitulated those observed in our 
analysis (Fig. 3) of patients with ACTA1 or NEB mutations. 
These included nuclear invaginations (Suppl Fig. S3a, b, 
online resource); reduced accumulation of heterochroma-
tin (Suppl Fig. S3a); increased accumulation of hetero-
chromatin (Suppl Fig. S3b, d, e); and separations between 
inner and outer nuclear membranes (Suppl Fig. S3c-e). A 
semi-quantitative analysis of these observations is shown 
in Table 5. These results indicate that nuclear defects also 
occur in presumably non-genetic phenocopies of NM, and 
also provide some correlative evidence that a reduction in 
force-generating capacity of muscle might underlie these 
defects (although other aspects of myofibre pathology might 
also contribute).
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Muscle fibres from NM patients and mouse models 
have disrupted cytoskeleton networks
In studies using cultured myotubes (an in vitro analogue 
of muscle fibre formation) and in developing Drosophila, 
the lateral spacing/positioning of myonuclei is known to 
be dependent on microtubules and motor proteins includ-
ing kinesins and dyneins [1, 12, 14, 35]. In addition, these 
motor proteins regulate nuclear shape during their trans-
location across nascent Drosophila fibres [14]. Given that 
we observe defects in nuclear morphology and spacing in 
NM patients, we sought to determine whether the microtu-
bule network and/or its associated proteins were perturbed. 
Microtubules are sensitive to temperature and rapidly 
depolymerise when tissue is kept cold or frozen [61], and 
therefore preservation of their structure is not compatible 
485Acta Neuropathologica (2019) 138:477–495 
1 3
with routine human muscle biopsy preparation. As a sur-
rogate, we aimed to analyse the localisation of pericentrin, 
a key microtubule organising centre protein (MTOC) that 
in skeletal muscle is found at the perinuclear regions, con-
sistent with the role of the myonucleus as a nucleator of 
microtubules. Using the same control subjects and patients 
from Fig. 2, We found that the localisation of pericentrin 
was markedly altered in NM patient myonuclei (Fig. 5a–d; 
note the rim of pericentrin around the nuclear surface, as 
well as nearby bright puncta in control subjects; note the 
increased accumulation of pericentrin immunolabelling at 
the nuclear surface in patients).
To further investigate microtubule organisation, we uti-
lised a mouse model of NM with a conditional knockout 
in the nebulin gene (Neb cKO) [28], and cardiac perfusion 
fixed with PFA, to allow the proper preservation of micro-
tubule structure. We found that microtubules at the cortex of 
skeletal muscle fibres were heavily disorganised compared 
to their control littermates (Fig. 6a, b). Note that the micro-
tubules in control animals appear as a regular grid-like lat-
tice, with denser accumulations around the nuclei (Fig. 6a, 
arrowheads). In mutants, however, the microtubule network 
was markedly disorganised, and the extent of accumulation 
around many of the myonuclei was visibly reduced (Fig. 6b, 
asterisks). Further analysis indicated that the microtubule 
network was denser in the mutant animals (Fig. 6e), and that 
their directionality was disturbed (Fig. 6f; a measurement 
made using the TeDT algorithm tool developed by Liu and 
Ralston [31]).
Desmin is a muscle-specific intermediate filament protein 
that connects myofibrils at the Z-discs, and links to other 
organelles including nuclei. We found that in most (~ 90%) 
of Neb cKO fibres, the normal Z-disc localisation of desmin 
was absent, and that its accumulation at the nuclear surface 
was not discernible (asterisks, Fig. 6c, d). Similar results 
were observed for cytoplasmic actins (β- and γ-) which form 
part of the cortical cytoskeleton. In control animals, both 
β- and γ-actin localised in striations, previously shown to be 
in alignment with Z-discs of the sarcomere (Fig. 6g–i) [43, 
50, 56]. However, in Neb cKO animals, both the striations 
and the nuclear regions of cytoplasmic actins were virtually 
absent, although γ-actin appeared as accumulations at the 
fibre periphery (Fig. 6j–l). Together these results indicate 
that microtubule, desmin and cytoplasmic actin networks 
are markedly altered in this mouse model of NM.
In addition, myonuclear shape analysis was performed on 
Neb cKO animals (Fig. 6m–p), and as in patients with NEB 
mutations (Fig. 2), nuclei were less elongated/more circu-
lar (Fig. 6n, o). In addition, both nuclear area (in 2D) and 
overall nuclear volume were increased in Neb cKO animals 
compared with controls (Fig. 6m, p).
Cytoskeletal organisation defines myonuclear 
properties
To investigate whether disorganisation of the cytoskeleton 
might cause nuclear abnormalities, intact muscle fibres were 
isolated enzymatically from mouse extensor digitorum lon-
gus (EDL) muscles, and cultured with and without drugs that 
modulate microtubule structure and dynamics. Overnight 
treatment with nocodazole resulted in an almost complete 
removal of microtubules (Fig. 7a, b, e), whereas treatment 
with taxol or Epothilone D (EpoD) resulted in increased 
microtubule density and reduced directionality score com-
pared with control/vehicle treated fibres (Fig. 7c–f). Noc-
odazole resulted in small shifts in nuclear morphology 
towards a more elongated, less circular phenotype (Fig. 7h, 
i; arrowhead in Fig. 7b indicates an example of an abnor-
mally elongated nucleus), although nuclear area as assessed 
in 2D was not affected (Fig. 7g). Treatment with taxol or 
EpoD resulted in an increase in nuclear area (X–Y planes) 
compared with control fibres (Fig. 7j, top row of panels; 
Fig. 7k), although no changes in aspect ratio or circularity 
were found (Fig. 7m, n). In addition, using 3D Z-stacks, we 
found similar nuclear volumes between control, taxol- and 
EpoD-treated fibres (Fig. 7l). This suggests that the increases 
in nuclear area observed with taxol and EpoD are caused 
by the nuclei spreading out/becoming flatter, rather than by 
an overall expansion of their total volume. Consistent with 
this, the lower panels in Fig. 7j show examples of the Z 
Fig. 3  Nuclear envelope and chromatin alterations in myonuclei of 
nemaline myopathy patients. Electron micrographs of patient muscle 
tissue, denoted with their mutation and age. a, a′ An example of an 
apparently relatively normal nucleus (N), with normal morphology, 
chromatin distribution, and a nuclear envelope consisting of a con-
tinuous double membrane marked “NE” (a′ is a magnified image of 
the boxed region in a). Nemaline rods (R) are seen in an adjacent 
fibre (a). The following nuclear abnormalities were also observed 
in patients: clusters of nuclei (b); reduced chromatin density (c); 
increased chromatin density (d, e, g, h); discontinuous patches of 
nuclear envelope (d, arrows); invaginations (e, denoted “inv”); and 
separation of the two nuclear membranes (e–h, denoted “sep”). Width 
of separation between inner and outer nuclear membranes in e–h is 
0.16, 0.89, 1.89, and 2.16 μm, respectively, (compared to apparently 
normal areas with separations measuring 25–40 nm (typical of nor-
mal nuclear envelope). i–k Skeletal muscle fibres were immunola-
belled with antibody against acetylhistone H3 (Lys9/Lys14), a marker 
of transcriptionally active regions of DNA (red). DNA is stained 
with DAPI (blue). Myonuclei from control subjects showed an even 
distribution of staining throughout the nuclei; however, in patients, 
some nuclei showed reduced fluorescence intensity, possibly indica-
tive of global transcriptional downregulation within certain nuclei 
(asterisks); and uneven distribution of staining, suggesting irregular 
packing of active genomic regions (arrowheads). Similar results were 
observed in one other control subject (age 30), and one other ACTA1 
and NEB patient (ages 30 and 56, respectively). 50+ nuclei were 
observed per subject across ~ 9 fibres for light microscopy. Quanti-
fications of acetylhistone H3 immunolabelling are found in Suppl 
Fig. S2 (online resource), and semi-quantitative analysis of electron 
microscopy findings in Table 4. Scale bar (i–k): 20 μm
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Table 4  Ultrastructural observations in myonuclei of nemaline myopathy patients
Categorisation is based on criteria described in Fig. 3. For chromatin density, ↑ denotes an increase in density (more heterochromatin) and ↓ a 
decrease in density (less heterochromatin). + indicates the presence of a given feature/observation. N denotes none observed. In all cases, two 
symbols indicate a particularly high incidence whereby the majority of observed myonuclei displayed the characteristic in question. 6–34 myo-
nuclei observed in all patients, across multiple fibres and fields of view, unless otherwise specified. Expected distance between inner and outer 
nuclear membranes is 20–40 nm, which was confirmed by our own measurements in regions of nuclei that appeared normal
Patient (mutation/age) Clusters of 
myonuclei
Chro-
matin 
density
Invaginations Separation of inner and outer nuclear membranes
NEB 2 (a) N ↑ + N
NEB 2 (b) N ↓↓ + N
NEB 17 + ↓↓ ++ N
NEB 23 ++ ↑ + ++ ~ 50% nuclei with separations ranging ~ 0.15–0.2 μm; 3 nuclei with sepa-
rations ranging 0.84–1.89 μm (34 nuclei studied in total)
NEB 30 + ↑ + + 3 nuclei with separations ranging 0.89–1.44 μm (25 nuclei studied in total)
ACTA1 11 weeks Only one nucleus image recorded + Separation of 2.16 μm
ACTA1 3 N ↓↓ N N
ACTA1 10 N ↓↓ N N
Fig. 4  Partial rescue of force production results in full restoration of 
nuclear spacing and morphology in the Acta1H40Y model of nemaline 
myopathy. a Scheme for mouse model published previously, where 
a gene therapy approach was used to deliver a transgene (Myl4) into 
tibialis anterior muscles [30]. Myl4 encodes a myosin light chain iso-
form (MyL4) normally only expressed in developing muscles, but 
when incorporated into the adult myosin complex, results in a myosin 
with increased force production (MHC, myosin heavy chain; RLC, 
regulatory light chain; MyL1, the endogenous myosin light chain). b 
Representative single skeletal muscle fibres from wild type (WT) and 
Acta1H40Y mice, treated with empty vector (Veh), or Myl4 transgene. 
Fibres were stained for actin (rhodamine phalloidin; red) and nuclei 
(DAPI; blue). c Order score (g), an algorithm to assess the regularity 
of nuclear spacing [4]; A lower score indicates more irregular spacing 
and more nuclear clustering. Nuclear shape measurements: nuclear 
area as observed in standard x, y planes (d), aspect ratio (e) and cir-
cularity (f). Note in c–f that the alterations in nuclear spacing and 
morphology observed in mutants were restored to wild-type levels 
when treated with Myl4 transgene. c One data point per muscle fibre; 
d–f one data point per nucleus analysed, mean ± SEM, with asterisks 
denoting significance versus WT/vehicle (one-way ANOVA). Scale 
bar: 50 μm. *P < 0.05, **P < 0.01, ***P < 0.001
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Table 5  Ultrastructural 
observations in myonuclei of 
patients with sporadic late-onset 
nemaline myopathy (SLONM, 
an acquired form of the disease)
See Table 3 for patient details, and recently published studies [36, 53]. Categorisation is based on criteria 
described in Fig. 3 and Suppl Fig. S3 (online resource). For chromatin density, ↑ denotes an increase in 
density (more heterochromatin) and ↓ a decrease in density (less heterochromatin). + indicates the pres-
ence of a given feature/observation. N denotes none observed. In all cases, two symbols indicates a par-
ticularly high incidence whereby the majority of observed myonuclei displayed the characteristic in ques-
tion. 6–15 myonuclei observed in all patients, across multiple fibres and fields of view. Expected distance 
between inner and outer nuclear membranes is 20–40 nm, which was confirmed by our own measurements 
in regions of nuclei that appeared normal
Patient (age) Clusters of 
myonuclei
Chromatin density Invaginations Separation of inner and 
outer nuclear membranes
SLONM 1 (65) + ↑↑, some ↓ ++ + 2 nuclei with separa-
tions of > 2 μm (15 
nuclei studied in 
total)
SLONM 2 (69) N ↑ + N
SLONM 3 (72) + ↑↑ + + 2 nuclei with 
separations 0.38 and 
0.85 μm (14 nuclei 
studied in total)
SLONM 4 (79) + ↑↑, some ↓ + N
SLONM 5 (34) N ↑↑ ++ N
Fig. 5  Distribution of the microtubule-organising centre around myo-
nuclei of nemaline myopathy patients. Healthy control subjects and 
patients are denoted with their mutation and age. a–c Representative 
images of nuclei immunolabelled for pericentrin (green) and DAPI 
(blue). Note specific arrangement of pericentrin in controls (nuclear 
surface and puncta) versus patients (marked accumulation at the 
nuclear surface). d Quantification of fluorescence intensity of peri-
centrin at the nuclear surface (within 2 μm of nearest nuclear (DAPI)-
labelled pixel). Quantification includes controls aged 25 and 30, two 
ACTA1 patients (20 and 30) and two NEB patients (36 and 56). Scale 
bar: 10 μm
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plane of the Z-stacks (orthogonal views), with nuclei appear-
ing flatter in this dimension. These results imply that the 
microtubule network exerts tension on the nuclear surface 
to regulate nuclear flattening.
It should be noted that myonuclear spacing was preserved 
in all drug-treated fibres relative to control, even after 72 h 
treatment (Fig. 7a–d and Suppl Fig. S4, online resource). 
Also, there were no gross changes in nesprin-1 localisation 
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with any of the drug treatments, suggesting that microtu-
bule disruption did not have any major effects on the nuclear 
envelope (Suppl Fig. S4). These results indicate that at least 
in non-contracting isolated muscle fibres, microtubule 
disruption for this length of time has no major impact on 
nuclear positioning or the nuclear envelope.
Discussion
In this study, we identify a range of nuclear and cytoskel-
etal defects in skeletal muscle fibres that occur as part of 
ACTA1 or NEB-related NM pathology. We show that such 
defects in nuclear morphology and spacing are caused by 
the impairment in force production that is a characteristic of 
this disease. We also highlight the role of the microtubule 
cytoskeleton in the regulation of nuclear shape.
Myonuclear spacing defects (Fig.  1) have also been 
observed in other mutant mouse models, including those 
in genes encoding nuclear envelope proteins (SUN1/SUN2 
double KO, Nesprin-1 KO [26, 57, 64]), and also in ageing 
[5]. Interestingly, this effect appears to be specific, since 
knockout of other nuclear envelope proteins such as lamin 
A/C does not significantly alter myonuclear organisation [16, 
27]. Currently, there is little insight into whether defects 
in nuclear spacing contribute to myofibre dysfunction, or 
whether they are merely a secondary phenomenon. How-
ever, given that regular spacing of myonuclei is a highly 
conserved feature across invertebrates and vertebrates, it is 
assumed that it is important for proper muscle fibre function, 
such as inter-nuclear cooperation and the efficient distribu-
tion of gene products throughout the cell [32]. Therefore, 
one might envisage that any deviation from a “normal” 
nuclear arrangement would result in sub-optimal muscle 
fibre function.
Studies to ascertain the mechanisms of nuclear spacing 
in skeletal muscle have largely taken place in myotubes and 
embryos of Drosophila and mouse, and have identified a 
number of mediators including nesprins, microtubules, 
MTOC proteins and the motor proteins kinesin and dynein 
[14, 15, 57]. Myotubes, as an in vitro system, are analo-
gous to the events during embryonic development, whereby 
myonuclei are located in the centre/core of the fibre, where 
their spacing takes place along the axis of the fibre. As such, 
myotubes are not anatomically or developmentally equiva-
lent to mature muscle fibres, in which nuclei are anchored 
at the fibre periphery. In these examples of NM, it is unclear 
whether the nuclear organisation defects are a result of aber-
rant spacing occurring during development, or in events that 
occur in maturity. However, our results show that nuclear 
positioning can be remodelled in mature fibres, since deliv-
ery of the Myl4 isoform into adult Acta1H40Y mice rescued 
nuclear spacing defects (Fig. 4). A key feature of muscle 
tissue in NM (as well as some other myopathies) is a shift 
towards type I fibres. This alone is unlikely to explain the 
alterations that we observed in NM patients, since no clear 
difference in the regularity of nuclear spacing is observed 
across human fibre types [9].
Various nuclear envelope and shape defects are also a 
feature of NM patients (Figs. 2, 3). Perhaps associated with 
this is the frequent observation of chromatin abnormalities 
in NM patients by EM and light microscopy (Fig. 3, Suppl 
Fig. S2, online resource), since both nuclear morphology 
and the nuclear envelope are known to play a role in tran-
scriptional regulation via chemical and mechanical control 
of chromatin organisation [10, 18, 23, 34, 58, 62]. Given 
that NM is caused by mutations in genes related to con-
traction, it would appear that these alterations are a second-
ary defect. However, many of these alterations bear strik-
ing resemblance to those seen in primary diseases of the 
nuclear envelope, for instance those caused by mutations 
in genes encoding, e.g., lamins, nesprins, or emerin, which 
frequently present with muscular dystrophy [2, 13, 19, 33, 
52, 55]. Given the severity of disease caused by mutations 
in genes encoding nuclear envelope proteins, it is likely that 
the array of nuclear defects that we describe in NM patients 
contributes to muscle dysfunction. Indeed, broad alterations 
in the transcriptional profile of skeletal muscle are observed 
in patients with NM (including in genes related to metabo-
lism and calcium homeostasis), and this may partially result 
from these characteristic nuclear shape and envelope altera-
tions and/or reorganised chromatin [51]. It should be noted 
that intranuclear rods are also a feature of some cases of 
NM, which might also be expected to affect nuclear func-
tion; however, we did not observe any instances of these in 
Fig. 6  Severe disruption of the cortical cytoskeleton in the Neb cKO 
mouse model of nemaline myopathy. Representative confocal micro-
graphs of skeletal muscle fibres in whole-mount extensor digitorum 
longus muscles of control (a, c) and Neb cKO mice (b, d); tissue 
was immunolabelled with antibodies to β-tubulin (a, b) or desmin 
(c, d) and nuclei were stained with DAPI (blue). In control muscles, 
the skeletal muscle fibre cortex shows a regular grid-like pattern for 
microtubules and a striated appearance for desmin; both are largely 
disorganised or reduced in mutants. Note the clustering of microtu-
bules and desmin at the periphery of nuclei, often altered or lacking 
in mutants. Quantifications of microtubule density (e), and direc-
tionality using previously developed algorithms [31] (f). Immunola-
belling for cytoplasmic (β- and γ-) actins, for control (g–i) and Neb 
cKO (j–l) mice; γ-actin (g, j), β-actin (h, k) and merged images (i, 
l). Note that microtubules, desmin and γ-actin show specific accumu-
lation at the surface and poles of nuclei (arrowheads), which is fre-
quently reduced or missing in mutants (asterisks). Observations were 
similar in three mutants and three control littermates. Graphs showing 
quantifications of nuclear shape parameters in muscle fibres: nuclear 
area (m), aspect ratio (n), circularity (o) and volume (p). Scale bars: 
20 μm. Graphs, mean ± SEM, two-tailed t test. *P < 0.05), **P < 0.01, 
***P < 0.001
◂
490 Acta Neuropathologica (2019) 138:477–495
1 3
Fig. 7  Pharmacological disruption of microtubule network structure 
results in alterations to nuclear morphology. Enzymatically dissoci-
ated single muscle fibres from wild-type mouse extensor digitorum 
muscles treated overnight with a DMSO (control), b Nocodazole, c 
taxol and d Epothilone D (EpoD). Microtubules are shown in grey 
(β-tubulin antibody), and nuclei in blue (DAPI). Quantifications of 
microtubule density (e), and directionality using previously devel-
oped algorithms [31] (f), in drug-treated fibres. Nuclear shape meas-
urements for control versus nocodazole-treated myofibres: nuclear 
area as observed in 2 dimensions (g), aspect ratio (h) and circular-
ity (i); these results show a modest shift towards more elongated 
nuclei with nocodazole treatment (arrowhead in B shows example of 
an elongated nucleus). Representative images of nuclei from myofi-
bres treated with DMSO, taxol and EpoD (j): upper row, nuclei as 
observed in standard x, y planes; lower row, orthogonal views of 
nuclei as seen in x, z planes. Nuclear shape measurements for con-
trol versus taxol- and EpoD-treated fibres: nuclear area as observed 
in standard x, y planes (k), nuclear volume (l), aspect ratio (m) and 
circularity (n). All graphs show mean ± SEM; one data point per 
nucleus in panels g–i, k–n. Microtubule and nuclear measurements 
were taken from multiple regions in eight fibres per condition, spread 
across 2–3 separate experiments for each condition. Asterisks denote 
significance versus DMSO/control-treated fibres. Scale bars: 10  μm 
(a–d) and 5 μm (j). Kolmogorov–Smirnov cumulative probability test 
was used to compare groups. *P < 0.05, **P < 0.01, ***P < 0.001
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the patient samples used in this study (either by EM, or by 
α-actinin staining in light microscopy samples).
Delivery of the Myl4 transgene to adult Acta1H40Y mouse 
muscles augments contractile force [30] and rescues nuclear 
spacing and morphology (Fig. 4). This suggests that (i) a 
lack of force originating at the sarcomere is responsible for 
these nuclear defects, and that (ii) this can be reversed by 
an increase in contractile capacity. The mediators of this 
effect are unclear, but may involve direct force transmis-
sion to the nuclei via, e.g., microtubule, actin or desmin 
cytoskeletons, or interactions through second messengers 
that may be responsive to mechanical input. Interestingly, 
nuclear defects at the ultrastructural level were also observed 
in patients with acquired forms of NM (SLONM; Suppl Fig 
S3, online resource; Table 5), where a reduction in muscle 
contractile force also occurs, but in the absence of muta-
tions in known disease-causing genes. This provides some 
evidence that contractile dysfunction is a cause of nuclear 
defects in humans, although this data are currently only 
supportive. In a broader sense, nuclear abnormalities might 
be common to other neuromuscular diseases, since various 
other classes of myopathy are also associated with impaired 
contraction [20]. One example that has been studied in detail 
is Marinesco–Sjögren syndrome, a multisystem disorder 
with myopathy, which is caused by mutations that affect 
endoplasmic reticulum trafficking and chaperone function 
[25, 46]. Ultrastructural abnormalities in myonuclei of this 
disorder include highly condensed chromatin and areas of 
nuclear envelope separation, akin to our observations in 
nemaline myopathy. It should be noted that disease etiology 
is highly variable across neuromuscular disorders, and that 
various aspects of muscle pathology might influence nuclear 
function and integrity, besides impaired contractile function.
Another of our key findings was the cytoskeletal defects 
in the Neb cKO model NM, involving microtubules, desmin 
and non-sarcomeric actins (Figs. 5, 6). Microtubules also 
show increased density and disorganisation in dystrophic 
mice with dystrophin or sarcoglycan deficiency, or mice 
with MAP6 ablation [3, 54]. In skeletal muscle, microtu-
bules are known to have roles in modulating fibre stiffness 
and contraction, and in signalling via reactive oxygen spe-
cies (ROS) [21]. Indeed, the increased microtubule density 
in dystrophic mice results in elevated ROS, over-activation 
of stretch-sensitive  Ca2+ channels, and worsened pathology 
[22]. In the mouse model of NM utilised in the present study, 
defects in non-sarcomeric (β- and γ-) actins and desmin were 
striking in that the vast majority of fibres showed markedly 
reduced/virtually absent localisation of all of these compo-
nents. Ablation of either β- or γ-actin specifically in skel-
etal muscle causes mild progressive myopathies [39], and 
loss of desmin causes disruptions of muscle architecture 
[6]. Intriguingly, myofibrils are frequently misaligned and 
disordered in NM [60], and this might be due to (i) the loss 
of desmin, and/or (ii) the defects at the nuclear envelope, 
since both are involved in the proper arrangement of myofi-
brils [1, 6]. One key role of desmin and actins is the lateral 
transmission of force to the fibre periphery, where actin and 
microtubules bind to the dystrophin-associated glycoprotein 
complex at the plasma membrane [3, 43, 56]. Therefore, the 
mislocalisation of these components is likely to have impli-
cations for the mechanical properties of the fibre.
Cytoskeletal components also have important roles in 
anchorage at the nucleus, and the normal localisation of 
microtubules, γ-actin and desmin at the nuclear surface were 
also largely reduced in Neb cKO mice. The cytoskeleton 
is likely to transmit strain from the mechanical forces of 
contraction to the nuclei, which may be important for fibre 
integrity and/or regulation of gene expression [8]. Consist-
ent with this, disruption of microtubules with several agents 
resulted in alterations to nuclear shape (Fig. 7). Although 
microtubules are known to regulate nuclear spacing dur-
ing development, no changes in nuclear distribution were 
observed when fibres were treated with nocodazole, taxol 
or EpoD (Fig. 7; Suppl Fig. S4, online resource). Possible 
explanations for this include: (i) other cytoskeletal systems 
are instead responsible for nuclear spacing in mature fibres, 
or are able to compensate when microtubules are disrupted; 
(ii) nuclei are more mobile in actively contracting fibres, 
which was not the case in these experiments; or (iii) longer 
treatments are required to induce significant remodelling of 
nuclei (which would not be preferable due to the relatively 
short-term viability of muscle fibres in ex vivo conditions).
The range of disease severity varies greatly in NM, and 
death in childhood is frequent at the most severe end of the 
spectrum. In this study, the patients were almost entirely 
of adult age, representing the milder end of the spectrum 
(with the exception of some early-onset cases included for 
electron microscopy studies). This was an experimental 
design choice, due to the availability of healthy human con-
trol tissue at adult, but not childhood ages. Therefore, it is 
difficult to draw extensive conclusions regarding nuclei in 
typical congenital cases of NM, although several early-onset 
cases displayed invaginations, altered chromatin compac-
tion and in one case, separation of inner and outer nuclear 
membranes (Fig. 3, Table 4). To date, our understanding 
of human muscle development at the cellular level during 
infancy and childhood is incomplete, and is likely to be 
highly dynamic throughout this period of sustained growth 
[11]. As such, interpretation of cellular organisation in con-
genital NM patients would be difficult, without appropriate 
information on healthy development.
In summary, our results demonstrate that skeletal muscle 
from NM patients and mouse models display defects in the 
non-sarcomeric cytoskeleton and in nuclear positioning and 
integrity. They indicate that abnormal nuclear spacing and 
morphology are the result of the impaired contractile force 
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production that is a key feature of this disease. In addition, 
we highlight the role of a properly organised cytoskeleton 
in the regulation of nuclear morphology. Although nuclear 
defects are observed in other diseases, including those caused 
by mutations in nuclear envelope proteins, these findings are 
somewhat unexpected, given that NM pathology originates 
at the sarcomere [7, 41]. They might explain some of the fea-
tures observed in NM, such as broad transcriptional changes 
and hindered muscle fibre growth (possibly related to altera-
tions in nuclear envelope and chromatin organisation, which 
is likely to affect programmes of gene expression [18, 34, 
62]), myofibrillar disarray (due to the roles of desmin and 
the nuclear envelope in sarcomere organisation [1, 6]) and 
altered fibre mechanical properties (due to disrupted cytoskel-
etal arrangements [21]). This study raises the possibility that 
nuclear and cytoskeletal defects may be an overlooked feature 
and/or source of pathology in other (muscle) diseases.
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